drugset / Trial / NCT06406166
Lifei Xiaoji Wan in Treatment of Advanced NSCLC
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is to evaluate the clinical efficacy of Lifei Xiaoji Wan for advanced non-small cell lung cancer (NSCLC), establish the treatment scheme, and obtain high-quality clinical evidence.
Timeline
- Start
- 2022-06-01
- Primary completion
- 2024-10-01
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lifei Xiaoji Wan | Traditional medicine (herbal / TCM) | 10 unknown | Oral |